Schedule 13G ownership disclosure

CATALYST BIOSCIENCES INC

Security class unavailable · CUSIP: 14888D208

Event date: 2018-02-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-18-000352
Form type
SC 13G/A
Filer
GYRE THERAPEUTICS, INC.
CIK
CIK 1124105
Filed
May 24, 2018
Reporting period
Feb 13, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub